NVP-BEZ235 [4], is a compound with dual PI3K/mTOR inhibitor activity, that acts as an ATP competitor and has been shown to significantly reduce tumor growth in a number of human xenograft models [5]–[10] and PI3K driven lung models [11]–[15]. This evidence concerns the gene MTOR and neoplasm.